Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7002 results

Sort By:

PLAT-08: a Study of SC-DARIC33 CAR T Cells in Pediatric and Young Adults with Relapsed or Refractory CD33+ AML

Study ID: NCT05105152
Start Date: 2021-11-29
End Date: 2041-01-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

18

Intervention / Treatment

SC-DARIC33

Sponsor

Seattle Children's Hospital

Source: clinicaltrials.gov

Share:
Add to list

A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Study ID: NCT04243785
Start Date: 2020-01-06
End Date: 2027-03
Study Type

Interventional

Study Phase

Phase1

No. of Participants

80

Intervention / Treatment

BTX-A51

Azacitidine

Sponsor

Edgewood Oncology Inc.

Source: clinicaltrials.gov

Share:
Add to list

A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis

Study ID: NCT06744920
Start Date: 2025-02-07
End Date: 2033-02-26
Study Type

Interventional

Study Phase

Phase3

No. of Participants

180

Intervention / Treatment

Remibrutinib (Blinded)

Placebo

Remibrutinib (Open Label)

Sponsor

Novartis Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer

Study ID: NCT06130826
Start Date: 2025-05-27
End Date: 2026-09-05
Study Type

Interventional

Study Phase

Phase1

No. of Participants

24

Intervention / Treatment

Biopsy

Biospecimen Collection

Bone Scan

Computed Tomography

Immunotherapy

Magnetic Resonance Imaging

Positron Emission Tomography

Stereotactic Body Radiation Therapy

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Study ID: NCT03959085
Start Date: 2019-10-31
End Date: 2030-03-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

4997

Intervention / Treatment

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Bone Scan

Calaspargase Pegol

Computed Tomography

Cyclophosphamide

Cytarabine

Daunorubicin Hydrochloride

Dexamethasone

Doxorubicin Hydrochloride

Inotuzumab Ozogamicin

Leucovorin calcium

Magnetic Resonance Imaging

Mercaptopurine

Methotrexate

Pegaspargase

Positron Emission Tomography

Prednisolone

Administration Questionnaire

Radiation Therapy

Radiation Therapy

Thioguanine

Vincristine Sulfate

Sponsor

Children's Oncology Group

Source: clinicaltrials.gov

Share:
Add to list

Defining Response Criteria for PET Scans for People With Neuroendocrine Tumors

Study ID: NCT06448208
Start Date: 2024-06-03
End Date: 2026-06
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

positron emission tomography (PET) scans

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

First-In-Human Study of STX-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations

Study ID: NCT06043817
Start Date: 2023-09-26
End Date: 2028-06-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

185

Intervention / Treatment

STX-721 (Escalated)

STX-721 (3 dose levels)

STX-721 (RP2D)

Sponsor

Antares Therapeutics, Inc

Source: clinicaltrials.gov

Share:
Add to list

TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer

Study ID: NCT05698576
Start Date: 2022-03-16
End Date: 2033-01-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

TRANBERG® Transperineal Fusion Laser--Induced Thermal Therapy of Prostate Cancer (TPF-LITT)

Sponsor

Urological Research Network, LLC

Source: clinicaltrials.gov

Share:
Add to list

Bladder Cancer Screening Trial

Study ID: NCT05646485
Start Date: 2023-05-05
End Date: 2028-04
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment

Urinalysis

Sponsor

University of Texas Southwestern Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Adaptive Symptom Self-Management Immunotherapy Study

Study ID: NCT05715255
Start Date: 2023-05-08
End Date: 2027-04-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

400

Intervention / Treatment

Automated Telephone Symptom Management (ATMS) and Telephone Interpersonal Counseling (TIP-C)

Active control comparator

Sponsor

University of Arizona

Source: clinicaltrials.gov

Share:
Add to list